- Home
- PYPD vs PHUN Comparison
PYPD vs PHUN Comparison
Compare PYPD & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- PHUN
- Stock Information
- Founded
- PYPD 2008
- PHUN 2009
- Country
- PYPD Israel
- PHUN United States
- Employees
- PYPD N/A
- PHUN N/A
- Industry
- PYPD Medical/Dental Instruments
- PHUN EDP Services
- Sector
- PYPD Health Care
- PHUN Technology
- Exchange
- PYPD Nasdaq
- PHUN Nasdaq
- Market Cap
- PYPD 54.7M
- PHUN 55.9M
- IPO Year
- PYPD 2020
- PHUN N/A
- Fundamental
- Price
- PYPD $3.80
- PHUN $2.54
- Analyst Decision
- PYPD Strong Buy
- PHUN Buy
- Analyst Count
- PYPD 5
- PHUN 2
- Target Price
- PYPD $12.00
- PHUN $7.75
- AVG Volume (30 Days)
- PYPD 92.7K
- PHUN 274.6K
- Earning Date
- PYPD 11-12-2025
- PHUN 11-13-2025
- Dividend Yield
- PYPD N/A
- PHUN N/A
- EPS Growth
- PYPD N/A
- PHUN N/A
- EPS
- PYPD N/A
- PHUN N/A
- Revenue
- PYPD N/A
- PHUN $2,400,000.00
- Revenue This Year
- PYPD N/A
- PHUN N/A
- Revenue Next Year
- PYPD N/A
- PHUN $72.40
- P/E Ratio
- PYPD N/A
- PHUN N/A
- Revenue Growth
- PYPD N/A
- PHUN N/A
- 52 Week Low
- PYPD $2.30
- PHUN $2.22
- 52 Week High
- PYPD $3.93
- PHUN $9.80
- Technical
- Relative Strength Index (RSI)
- PYPD 68.11
- PHUN 40.01
- Support Level
- PYPD $3.10
- PHUN $2.57
- Resistance Level
- PYPD $3.50
- PHUN $2.84
- Average True Range (ATR)
- PYPD 0.18
- PHUN 0.16
- MACD
- PYPD 0.06
- PHUN -0.03
- Stochastic Oscillator
- PYPD 94.87
- PHUN 8.36
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.